In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Zotinar Drug Master File in Korea (Zotinar KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Zotinar. The MFDS reviews the Zotinar KDMF as part of the drug registration process and uses the information provided in the Zotinar KDMF to evaluate the safety and efficacy of the drug.
After submitting a Zotinar KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Zotinar API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Zotinar suppliers with KDMF on PharmaCompass.